Immatics NV (IMTX)
11.22
+0.52
(+4.86%)
USD |
NASDAQ |
May 20, 16:00
11.22
0.00 (0.00%)
After-Hours: 20:00
Immatics Shareholders Equity (Quarterly) : 525.17M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Epigenomics AG | -- |
| MediGene AG | -- |
| InflaRx NV | 42.50M |
| BioNTech SE | 21.54B |
| CureVac NV | 1.024B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 625.95M |
| Total Liabilities (Quarterly) | 100.77M |
| Debt to Equity Ratio | 0.0331 |
| Current Ratio | 8.775 |
| Net Debt Paydown Yield | 0.02% |